Effect of tofogliflozin on obesity-related health problems in patients with type 2 diabetes and overweight or obesity-a post-hoc sub-analysis of the UTOPIA study. [PDF]
Katakami N +5 more
europepmc +1 more source
Impact of SGLT2 Inhibitors on Mortality Across Different Populations: A Systematic Review and Meta-Analysis. [PDF]
Movila DE +6 more
europepmc +1 more source
Trends in sodium-glucose transport protein 2 inhibitor prescriptions: application of the ATC/DDD system to NDB open data. [PDF]
Miyake T, Hashimoto M, Kadowaki D.
europepmc +1 more source
SGLT2 Inhibitors in Autosomal Dominant Polycystic Kidney Disease: A Systematic Review and Meta-Analysis. [PDF]
Tantush A +12 more
europepmc +1 more source
Impact of Sodium-Glucose Co-Transporter-2 (SGLT2) Inhibitors on Nocturnal Polyuria: A Cross-Sectional Study. [PDF]
Sato S +7 more
europepmc +1 more source
Pharmacokinetic Landscape and Interaction Potential of SGLT2 Inhibitors: Bridging In Vitro Findings and Clinical Implications. [PDF]
Koo N +4 more
europepmc +1 more source
Comparison of the efficacy of antidiabetic agents in type 2 diabetes with MASLD: a network meta-analysis. [PDF]
Shao X, You J, Zhang H, Jiang X.
europepmc +1 more source
Effects of Progranulin Deficiency on Inflammation and Fibrosis in the Kidneys and Liver of Diabetic Mice Fed a High-Fat Diet. [PDF]
Sakuma H +5 more
europepmc +1 more source
SO019RENAL AUTONOMIC NERVES ARE RESPONSIBLE FOR BODY WEIGHT REDUCTION BY TOFOGLIFLOZIN [PDF]
openaire +1 more source
Effect of Oral Hypoglycaemic Agents on Carotid Artery Intima-Media Thickness in Patients With Cardiovascular Disease and/or Diabetes-A Systematic Review. [PDF]
Shabu A +4 more
europepmc +1 more source

